Wikipedia:WikiProject Medicine/Dermatology task force/Missing articles/LeBoit

Add links
Source: Wikipedia, the free encyclopedia.
  1. ABCD
  2. ABCDE criteria
  3. Abrikossoff tumour
  4. Acantholytic acanthoma
  5. Acantholytic squamous cell carcinoma
  6. Acanthoma
  7. Acanthosis nigricans
  8. Accessory tragus
  9. Acetylcholinesterase
  10. Acid mucopolysaccharides
  11. Ackerman tumour
  12. Acquired progressive lymphangioma
  13. Acquired ungual fibrokeratoma
  14. Acral arteriovenous tumour
  15. Acral fibrokeratoma
  16. Acral lentiginous melanoma
  17. Acral melanoma
  18. Acral naevus
  19. APACHE
  20. Acral verrucous hyperkeratosis
  21. Acrochordon
  22. Acrodermatitis enteropathica
  23. Acromegaly
  24. Acrospiroma
  25. Acrosyringeal adenomatosis
  26. Acrosyringia
  27. Acrotrichium
  28. Actinic elastosis
  29. Actinic keratoses
  30. Actinic lentigo
  31. Actinic reticuloid
  32. Activated skin-homing T-cell
  33. Acute lymphoblastic leukaemia
  34. Acute lymphocytic leukaemia
  35. Acute monoblastic/monocytic leukaemia - AMOL
  36. Acute myeloid leukaemia - AML
  37. Acute myelomonocytic leukemia - AMML
  38. Adamantinoid trichoblastoma
  39. Adenoid basal cell carcinoma
  40. Adenoid cystic carcinoma
  41. Adenopathy
  42. Adenosquamous carcinoma
  43. Adnexal basaloid tumours
  44. Adnexal carcinoma
  45. ATLL
  46. AE
  47. AE1
  48. AE2
  49. AE
  50. AE
  51. Aggressive digital papillary adenoma
  52. Aggressive systemic mastocytosis
  53. Agminated blue naevus
  54. AIDS
  55. AJCC classification
  56. ALCL
  57. Alcoholic cirrhosis
  58. ALHE
  59. ALK
  60. Alkylating agent
  61. Allergic contact dermatitis
  62. ALM
  63. Alopecia
  64. Alpha SMA
  65. Alpha-1 antichymotrypsin
  66. Alpha-1-ACT
  67. Alpha-1-antitrypsin
  68. Alpha-smooth muscle actin
  69. Amelanotic melanoma
  70. Amelanotic nodular melanoma
  71. AJCC
  72. American Joint Committee on Cancer
  73. Acute myeloid leukaemia
  74. AMML see Acute myelomonocytic leukemia
  75. AMNGT see Atypical melanocytic naevus of the genital type
  76. AMOL see Acute monoblastic/monocytic leukaemia
  77. Amputation neuroma
  78. Anaphylaxis
  79. Anaplastic large cell lymphoma
  80. Anaplastic lymphoma
  81. Anaplastic lymphoma related tyrosine kinase - ALK
  82. Aneurysmal fibrous histiocytoma
  83. Angioblastoma of Nakagawa
  84. Angiocentric cutaneous T-cell lymphoma of childhood
  85. Angiocentric immunoproliferative lesion
  86. Angiocentric lymphoma
  87. Angiocentric T-cell lymphoma
  88. Angioendotheliomatosis
  89. Angioendotheliomatosis proliferans systematisata
  90. Angiofibroma
  91. Angioimmunoblastic T-cell lymphoma - AITL
  92. Angiokeratoma
  93. Angiokeratoma circumscriptum naeviforme
  94. Angiokeratoma corporis diffusum
  95. Angiokeratoma corporis diffusum in
  96. Fabry disease
  97. Angiokeratoma corporis diffusum
  98. Mibelli and Fordyce
  99. Angiokeratoma of Fordyce
  100. Angiokeratoma
  101. Angiokeratoma of Fabry disease
  102. Angioleiomyoma
  103. Angiolymphoid hyperplasia with eosinophilia - ALHE
  104. Angiomatoid fibrous histiocytoma
  105. Angiosarcoma
  106. Angiotropic large cell lymphoma
  107. Anhidrosis
  108. Anhidrotic ectodermal dysplasia gene product
  109. Animal type melanoma - epithelial melanocytoma
  110. Anisodendrocytosis
  111. Anogenital verrucous carcinoma
  112. Antiphospholipid syndrome
  113. AP-1 transcription factor complex
  114. APC
  115. Apical snouts
  116. Apocrine adenocarcinoma
  117. Apocrine adenocarcinoma in situ
  118. Apocrine adenoma
  119. Apocrine carcinoma
  120. Apocrine cystadenoma
  121. Apocrine gland carcinoma
  122. Apocrine gland cyst
  123. Apocrine hidrocystoma
  124. Apocrine mammary carcinoma
  125. Apoptosis
  126. Apoptotic bodies
  127. Appendageal tumous
  128. Apudoma
  129. Array CGH
  130. Arrector pili hamartoma
  131. Arrector pili muscles
  132. Arsenic
  133. Arsenic exposure
  134. Arsenical keratosis - As-K
  135. Arteriovenous anastomoses
  136. Arteriovenous haemangioma
  137. Arteriovenous malformation
  138. Arthropod bite
  139. Asthma
  140. Astrocytoma of the spinal cord
  141. Ataxia telangiectasia
  142. ATLL see A dult T cell leukaemia / lymphoma
  143. Atrophic dermatofibroma
  144. Atypical fibrous histiocytoma
  145. ALMP
  146. Atypical melanocytic naevus of the genital type - AMNGT
  147. Atypical mixed tumour of the skin
  148. Atypical naevus
  149. Atypical nodular melanocytic proliferation
  150. Atypical pigmented spindle cell naevus
  151. Atypical proliferative nodules in giant congenital naevi
  152. Bacillary angiomatosis
  153. Bacille Calmette-Guérin - BCG vaccine
  154. Back to back appearance
  155. BRRS
  156. Bartonella bacteria
  157. Basal cell carcinoma
  158. Basal cell carcinoma with adnexal differentiation
  159. Basal cell epithelioma
  160. Basal cell epithelioma with sebaceous differentiation
  161. Basal cell naevus syndrome - BCNS
  162. Basaloid squamous cell carcinoma
  163. Basaloid follicular hamartoma
  164. Basaloid sebaceous carcinoma
  165. bFGF
  166. Basosquamous carcinoma
  167. Basosquamous cell carcinoma
  168. Basal cell carcinoma
  169. B-cell lymphoblastic leukaemia/ lymphoma
  170. B-cell lymphoma
  171. BCL
  172. Bcl
  173. Bcl
  174. BCNS see Basal cell naevus syndrome
  175. Becker naevus
  176. Bednar tumour
  177. Benign calcifying epithelioma
  178. Benign juvenile melanoma
  179. Benign lichenoid keratosis
  180. Benign lymphangioendothelioma
  181. Benign lymphangiomatous papules
  182. Ber-EP
  183. Beta 2 microglobulin
  184. BF
  185. BFGF
  186. BHD gene
  187. Birbeck granules
  188. Birds-eye cells
  189. Birt-Hogg-Dubé syndrome - BHD
  190. B-K mole syndrome
  191. Blastic NK-cell lymphoma
  192. Blastoid NK-cell lymphoma
  193. Bloom syndrome
  194. Blue naevi
  195. Blue naevus-like melanoma
  196. Blueberry muffin syndrome
  197. BMPR1A
  198. Bombesin
  199. Bone morphogenic protein receptor type 1A gene - BMPR1A
  200. Borrelia
  201. Borrelia burgdorferi
  202. Borrelia infection
  203. Borrelia-induced pseudolymphoma
  204. Bourneville disease see Tuberous sclerosis
  205. Bowen disease
  206. Bowen or Paget disease
  207. Bowenoid actinic keratoses - BAK
  208. Bowenoid dysplasia
  209. Bowenoid papulosis
  210. Bowenoid solar keratosis
  211. Bowenoid squamous carcinoma in situ - BSCIS
  212. BRAF
  213. BRAF mutations
  214. Breast cancer
  215. Breast carcinoma
  216. Breast fibroadenoma
  217. Breslow thickness
  218. Brocq disease
  219. Bromide compounds
  220. Brooke-Fordyce disease
  221. Brooke-Spiegler disease
  222. Brooke-Spiegler syndrome
  223. Brook-Fordyce disease
  224. Bullous pemphigoid
  225. Bunn-Lamberg staging system
  226. Burkitt lymphoma
  227. Burn scar
  228. Buschke-Löwenstein tumour
  229. -Butoxyehtanol solvent
  230. C to T mutation
  231. CA15.
  232. Café-au-lait spots
  233. Calcification
  234. Calcifying epithelioma of Malherbe
  235. Calcitonin
  236. C-ALCL
  237. Callus
  238. Calretinin
  239. CAM 5.
  240. Campbell de Morgan spots
  241. Candidiasis
  242. Caput Medusae pattern
  243. Carbonic anhydrase
  244. Carcinoembryonic antigen
  245. Carcinoma in-situ - CIS
  246. Carcinoma of the Bartholins glands
  247. Cardiac arrhythmia
  248. Cardiac insufficiency
  249. Cardiac myxoma
  250. Cardiac myxoma emboli
  251. Cardiopulmonary
  252. Carney complex
  253. Cathepisin B
  254. Cavernous haemangioma
  255. CC to TT mutation
  256. CCND1/cyclin D
  257. CD1a
  258. CD2
  259. CD3
  260. CD3e
  261. CD4
  262. CD4+, CD56+ - agranular haematodermic neoplasm
  263. CD5
  264. CD6
  265. CD7
  266. CD8+ - cytotoxic T cell lymphoma
    ]]
  267. CD10
  268. CD11c
  269. CD14
  270. CD15
  271. CD19
  272. CD20
  273. CD21
  274. CD22
  275. CD23
  276. CD24
  277. CD25 - interleukin 2-receptor
  278. CD26
  279. CD30
  280. CD30+ - T-cell lymphoproliferative disorders
  281. CD30L
  282. CD30-positive - T-cell lymphoproliferative disorders - LPD of the skin - CD30+LPD)
  283. CD31
  284. CD34
  285. CD34+ - haematopoetic precursor cells
  286. CD35
  287. CD38
  288. CD43
  289. CD44
  290. CD45
  291. CD45RO
  292. CD56
  293. Leu-7
  294. CD68
  295. CD71
  296. CD74
  297. CD79a
  298. CD95 - Fas
  299. CD99
  300. CD117
  301. CD123
  302. CD138
  303. CD207 - langerin
  304. CDK
  305. CDKN2A - p16
  306. CDKN2A germline mutation
  307. CEA
  308. Cell adhesion molecule
  309. Cell division kinase
  310. Cellular blue naevus
  311. Cellular fibrous histiocytoma
  312. Cellular neurothekeoma
  313. C-erbB-2/HER-2/neu
  314. Cerebriform nuclei
  315. Ceruminous gland carcinoma
  316. CGD-TCL
  317. CGH see Comparative genomic hybridization
  318. Chemotherapy
  319. Cherry haemangioma
  320. Cherry-type haemangioma
  321. Childhood melanoma
  322. Chimeric COL1A1-PDGFB gene
  323. Classical Hodgkin lymphoma
  324. Chloroma
  325. Chondroid syringoma
  326. Chromogranin
  327. Chromosomal translocation
  328. Chromosome 1 - 1p36
  329. Chromosome 11q
  330. Chromosome 13q
  331. Chromosome 16q12-q
  332. Chromosome 17p11.
  333. Chromosome 6q deletion
  334. Chromosome 9p
  335. Chromosome 9q22-q
  336. Chronic actinic reticuloid
  337. Chronic arsenism
  338. Chronic lymphatic leukaemia
  339. Chronic lymphocytic leukaemia
  340. Chronic lymphocytic leukaemia/small lymphocytic lymphoma
  341. Chronic myelogenous leukaemia - CML
  342. Chronic myelomonocytic leukaemia - CMML
  343. Chronic superficial dermatitis
  344. Chylothorax
  345. Chylous ascites
  346. Cirsoid aneurysm
  347. CK5
  348. CK14
  349. CK15
  350. CK7
  351. CK20
  352. C-KIT
  353. C-KIT mutations
  354. CLA
  355. Clark model
  356. Clark naevus
  357. Clark’s levels of invasion
  358. Classical Hodgkin lymphoma - CHL
  359. Clear basal cell carcinoma
  360. Clear cell acanthoma
  361. Clear cell hidradenoma
  362. Clear cell papulosis
  363. Clear cell sarcoma
  364. Clear cells of Toker
  365. Clear-cell eccrine carcinoma
  366. Clear-cell hidradenocarcinoma
  367. Clear-cell papillary carcinoma
  368. Clear-cell squamous cell carcinoma
  369. Clear-cell syringoma
  370. Cleft lip
  371. Clonal dermatitis
  372. Clonal rearrangement of T cell receptor genes
  373. Clonal seborrhoeic keratosis
  374. Clonally rearranged IgH genes
  375. Clonally rearranged immunoglobulin genes
  376. Clonally rearranged T-cell receptor gene
  377. Chronic myelogenous leukaemia
  378. CMM1
  379. Chronic myelomonocytic leukaemia
  380. C-MYC
  381. C-MYC mutations
  382. C-MYC translocation
  383. CNC1 gene
  384. CNC2 gene
  385. Coagulative defects
  386. Cobb syndrome
  387. Cocco-bacillary organisms
  388. Cockayne syndrome
  389. Collagen ball formation
  390. Collagen type IV
  391. Colloid, gelatinous and adenocystic carcinoma
  392. Coloboma
  393. Colonic polyps
  394. Columnar trichoblastoma
  395. Combined dermatofibroma
  396. Combined naevus
  397. Comedonal Darier disease
  398. Common acquired melanocytic naevi
  399. Common basal cell carcinoma
  400. Common blue naevus - BN
  401. Common wart
  402. Comparative genomic hybridization - CGH
  403. genital warts
  404. Condylomata plana - flat cervical condylomas - plane condylomas
  405. Congenital fibrosarcoma
  406. Congenital generalized fibromatosis
  407. Congenital ichthyosiform erythroderma
  408. Congenital leukaemic infiltrates
  409. Congenital lymphoedema
  410. Congenital melanocytic naevi - CMN
  411. Congenital melanoma
  412. Congenital mesenchymal hamartoma
  413. Congenital midline hamartoma
  414. Congenital naevi of the meninges
  415. Congenital naevus
  416. Congenital naevus-like naevus
  417. Congenital non-progressive haemangioma
  418. Congenital pattern-like naevus
  419. Congenital pilar and smooth muscle naevus
  420. Congenital reticulohistiocytosis
  421. Congenital self-healing Langerhans cell histiocytosis
  422. Congenital self-healing reticulohistiocytosis - CSHRH
  423. Congenital smooth muscle naevus
  424. Consumption of the epidermis
  425. Contraceptive pills
  426. Cornea verticillata
  427. Corneocytes
  428. Cowden disease
  429. Cowden syndrome - CS
  430. Craniofacial clefts
  431. Cribriform trichoblastoma
  432. Crusts
  433. Cryoglobulinaemia
  434. CSHRH
  435. CT
  436. CTNNB
  437. CU18
  438. Cushing syndrome
  439. Cutaneous (dermal) leiomyosarcoma
  440. Cutaneous adnexal carcinoma
  441. Cutaneous adult T-cell leukaemia / lymphoma
  442. Cutaneous angiosarcoma
  443. Cutaneous B-cell lymphoma - CBCL
  444. Cutaneous B-cell pseudolymphoma - B-PSL
  445. Cutaneous diffuse large B-cell lymphoma
  446. Cutaneous follicle centre lymphoma - FCL
  447. Cutaneous follicular lymphoid hyperplasia with monotypic plasma cells
  448. Cutaneous follicular lymphoid hyperplasia - monotypic plasma cells
  449. Cutaneous gd T-cell lymphoma - CGD-TCL
  450. Cutaneous histiocytoid angioma
  451. Cutaneous involvement by myeloid leukaemia
  452. Cutaneous involvement in primary extracutaneous B-cell lymphoma
  453. Cutaneous involvement in primary extracutaneous T-cell lymphoma
  454. Primary extracutaneous B-cell lymphoma
  455. Primary extracutaneous T-cell lymphoma
  456. Cutaneous leiomyosarcoma
  457. Cutaneous lichen amyloidosis
  458. Cutaneous lobular neuromyxoma
  459. Cutaneous lymphocyte antigen - CLA
  460. Cutaneous lymphoid hyperplasia
  461. Cutaneous lymphoproliferative disorders - CLD
  462. Cutaneous malignant melanoma
  463. Cutaneous marginal zone B-cell lymphoma
  464. Cutaneous mastocytosis - CM
  465. Cutaneous melanoma
  466. Cutaneous pseudolymphoma
  467. Cutaneous reticulohistiocytoma
  468. Cutaneous sebaceous neoplasms
  469. CTCL
  470. Cutaneous T-cell pseudolymphoma - T-PSL
  471. Cyclin D1
  472. Cyclin-dependent kinase inhibitor
  473. Cyclin-dependent kinase inhibitor 2A
  474. Cyclin-dependent kinase
  475. Cyclindroma
  476. CYLD1
  477. Cylindroma
  478. Cylindrospiradenoma
  479. Cystic BCC
  480. Cystic sebaceous tumour
  481. Cytophagic panniculitis
  482. Cytoplasmic CD
  483. Cytoplasmic intermediate filaments
  484. Cytotoxic gd T-cells
  485. Cytotoxic T-cell lymphoma
  486. Cytotoxic T-cells
  487. Darier sign
  488. D2-40
  489. DDB2
  490. DDBI
  491. De Morgan spots
  492. Deep foot warts
  493. Deep penetrating naevi
  494. Deeply pigmented seborrhoeic keratosis
  495. Definite malignant lymphoma of high-grade malignancy - LHM
  496. Definite malignant lymphoma of low-grade malignancy (LLM
  497. Degos acanthoma
  498. Delleman syndrome
  499. Dendritic cells
  500. Dermal duct tumour
  501. Dermal leiomyosarcoma
  502. Dermal melanocytic tumour of uncertain potential in a giant congenital naevus
  503. Dermal variant of minimal deviation melanoma in a giant congenital naevus
  504. Dermatofibroma
  505. fibrous histiocytoma
  506. Dermatofibroma with monster cells
  507. Dermatofibrosarcoma protuberans
  508. Dermatomyofibroma
  509. Dermatomyositis
  510. Dermatoscopy
  511. Dermatosis
  512. Dermatosis papulosa nigra
  513. Dermographism
  514. Dermoscopy
  515. De-Sanctis Cacchione syndrome
  516. Desmin
  517. Desmoplasia
  518. Desmoplastic melanoma
  519. Desmoplastic naevus
  520. Desmoplastic neurotropic melanoma - DNM
  521. Desmoplastic squamous cell carcinoma
  522. Desmoplastic Spitz naevus
  523. Desmoplastic trichoepithelioma
  524. Desmoplastic/neurotropic melanoma
  525. Diabetes insipidus
  526. Diabetes mellitus
  527. Diffuse cutaneous mastocytosis
  528. Diffuse dermal angiomatosis
  529. DLBCL
  530. Diffuse neonatal haemangiomatosis
  531. Digital fibrokeratoma
  532. Digital focal mucinosis
  533. Digital mucous cyst
  534. Digital papillary adenocarcinoma
  535. Digital papillary carcinoma
  536. Digitate dermatosis
  537. Dilated pore - Winer
  538. Dioxin
  539. Diphenylhydantoin
  540. Diplopia
  541. Disseminated pyogenic granuloma
  542. DLBCL
  543. DNA mismatch repair
  544. DNA repair
  545. DNA repair genes
  546. Dowling Degos disease
  547. Down syndrome
  548. Ductal adenocarcinoma of the breast
  549. Ductal carcinoma in situ - DCIS
  550. Dutcher bodies
  551. Dyskeratosis
  552. Dyskeratosis with acantholysis - warty dyskeratoma
  553. Dysplastic (Clark) naevus
  554. Dysplastic combined blue naevus
  555. Dysplastic halo naevus
  556. Dysplastic naevus - DN
  557. Dysplastic naevus syndrome
  558. Dysplastic naevus with a congenital pattern
  559. Dysplastic neuronaevus
  560. Dysplastic Spitz naevus
  561. E4 proteins
  562. Early nodular melanoma
  563. EBER
  564. EBV
  565. E-cadherin
  566. Eccrine epithelioma
  567. Eccrine hidrocystoma
  568. Eccrine porocarcinoma
  569. Eccrine poroma
  570. Eccrine syringofibroadenoma
  571. Eccrine syringofibroadenomatous hyperplasia
  572. Eccrine syringoma
  573. Ectropion
  574. Eczema
  575. Eczematous halo
  576. Elevatum diutinum
  577. EMA
  578. Endocrine tumour
  579. Endoneurial fibroblast
  580. Endophytic common wart
  581. Enteropathy-type T-cell lymphoma
  582. Entropion
  583. EORTC
  584. Eosinophilia
  585. Eosinophilic bodies
  586. Eosinophilic granuloma
  587. Epidermal cyst
  588. Epidermal dysplasia
  589. Epidermodysplasia verruciformis - EV
  590. Epidermodysplasia-verruciformis - HPV types
  591. Epidermoid carcinoma in sebaceous cyst
  592. Epidermoid cysts
  593. Epidermolytic acanthoma
  594. Epidermolytic hyperkeratosis
  595. Epidermotropic eccrine carcinoma
  596. Epidermotropic metastasis
  597. Epidermotropism
  598. Epiluminescence microscopy
  599. Epiluminescence microscopy
  600. Epithelial melanocytoma
  601. Epithelioid angiomatosis
  602. Epithelioid angiosarcoma
  603. Epithelioid cell histiocytoma
  604. Epithelioid haemangioma
  605. Epithelioid sarcoma
  606. Epithelioma cuniculatum
  607. Epstein Barr
  608. EBV
  609. ERCC1
  610. ERCC2
  611. ERCC4
  612. ERCC5
  613. Eruptive syringoma
  614. Erythema
  615. Erythematous nodule
  616. Erythematous scaly patches
  617. Erythroderma
  618. Erythrodermic CTCL
  619. Erythroplasia of Queyrat - EPQ
  620. Ewing sarcoma
  621. EWS gene
  622. Exophthalmos
  623. Expansile pattern of growth
  624. Extramammary Paget disease
  625. Extramammary Paget’s cells
  626. Extramedullary myeloid sarcoma
  627. Extranodal marginal zone B-cell lymphoma
  628. Extranodal NK/T-cell lymphoma
  629. Extranodal NK/T-cell lymphoma, nasal-type
  630. Extraskeletal Ewing sarcoma
  631. Eyelid hidrocystoma
  632. Fabry disease
  633. Factor VIII
  634. Factor VIII-related antigen
  635. Factor XIII
  636. Factor XIIIa
  637. Familial atypical mole-malignant melanoma syndrome, FAMMM
  638. Familial atypical mole-melanoma syndrome
  639. Familial atypical multiple mole melanoma pancreatic carcinoma syndrome - FAMMMPC
  640. Familial cancer syndromes
  641. Familial cutaneous melanoma
  642. Familial dyskeratotic comedones
  643. Familial melanoma
  644. Familial multiple trichoblastoma and cylindroma - Brooke-Spiegler disease
  645. Fanconi anaemia
  646. Faulty hair matrix
  647. FCC
  648. FcgRII
  649. FCL
  650. Ferguson Smith type keratoacanthoma
  651. Ferguson Smith type of “multiple self-healing epitheliomas”
  652. Fetal rhabdomyoma
  653. Fibrocytokines
  654. Fibroepithelial polyp
  655. Fibroepithelioma of Pinkus
  656. Fibroepithelioma
  657. Fibroepithelial basal celll carcinoma
  658. Fibroepithelial polyp
  659. Fibrofolliculoma
  660. Fibroma durum
  661. Fibroma
  662. Fibromatous Tumours of the Skin
  663. Fibromin
  664. Fibroplasia
  665. Fibrosarcoma
  666. Fibrosclerosis
  667. Fibrous hamartoma of infancy
  668. Fibrous histiocytoma
  669. Fibrous papule of the face
  670. FIGO - Fédération Internationale de
  671. Gynécologie et d’Obstétrique
  672. Fine-needle aspiration cytology
  673. FISH
  674. Fitzpatrick skin types
  675. Flat macule
  676. Flat seborrhoeic keratosis
  677. Flat wart
  678. FLI-1
  679. Fluorouracil
  680. Focal epithelial hyperplasia - Heck’s disease
  681. Follicular adenocarcinoma
  682. Follicular centre cell lymphoma
  683. Follicular dyskeratoma
  684. Follicular hyperkeratosis
  685. Follicular infundibulum
  686. Follicular MF
  687. Follicular stroma
  688. Folliculo-sebaceous cystic hamartoma
  689. Folliculotropic MF
  690. Fordyce angiokeratoma
  691. Foreign body
  692. Fungal disorder
  693. Ganglion of the distal interphalangeal joint
  694. Gardner syndrome
  695. Gasoline
  696. Gastrin
  697. Gastrointestinal stromal tumours - GISTs
  698. Gata
  699. GCDFP-15
  700. Gene rearrangement of immunoglobulin heavy chain genes, and T-cell receptor genes
  701. Generalized cutaneous histiocytosis - GCR
  702. Generalized lymphangioma
  703. Genital melanosis/lentiginosis
  704. Genital naevus
  705. Genital naevus with unusual histologic features
  706. Genodermatosis
  707. Germinative cells
  708. Germline
  709. Germline mutations
  710. GFAP
  711. Ghost vessels
  712. Giant cell fibroblastoma
  713. Giant cell histiocytosis
  714. Giant cell reticulohistiocytosis
  715. Giant condyloma acuminata - Buschke-Lowenstein tumour
  716. Giant condyloma acuminatum
  717. Giant congenital naevus - GCN
  718. Giant hair matrix tumour
  719. Giant keratoacanthoma
  720. Glabrous skin
  721. Glans penis
  722. GLI
  723. Glomeruloid haemangioma
  724. Glomus tumour
  725. Glucose-6-phosphate dehydrogenase
  726. GLUT
  727. Glutathione-S-transferase null genotype
  728. Goldenhar syndrome
  729. Gorlin syndrome
  730. Gorlin-Goltz syndrome
  731. Gp
  732. Gp100 - recognized by HMB45
  733. Grain leather
  734. Granular cell dermatofibroma
  735. Granular cell epulis of infancy
  736. Granular cell myoblastoma
  737. Granular cell nerve sheath tumour
  738. Granular cell Schwannoma
  739. Granular cell tumours - GCT
  740. Granular-cell
  741. Granulocytic sarcoma
  742. Granuloma faciale
  743. Granulomatous inflammation
  744. Granulomatous MF
  745. Granulomatous slack skin
  746. Granzyme B
  747. Granzyme M - metase
  748. Grenz zone
  749. Gross cystic disease fluid protein - GCDFP
  750. Grover disease
  751. Grzybowski type keratoacanthoma
  752. GTPase-activating protein
  753. Haemangioma
  754. Haemangioma of infancy
  755. Haemangioma unilateralis naeviforme
  756. Haemangiopericytoma-like fibrous histiocytoma
  757. Haemangiosarcoma
  758. Haematopoietic stem cells
  759. Haemophagocytic syndrome
  760. Hailey-Hailey disease
  761. Hair disk - Haarscheibe
  762. Hair follicle hamartoma
  763. Hair follicle naevus
  764. Halo dermatitis
  765. Halo eczema
  766. Halo naevus
  767. HAM56
  768. Hamartin
  769. Hamartoma
  770. Hand-Schüller-Christian-disease
  771. Hashimoto thyroiditis
  772. Hashimoto-Pritzker disease
  773. Hashimoto-Pritzker type
  774. H-caldesmon
  775. Heck’s disease
  776. Hedgehog signaling pathway
  777. Hepatosplenomegaly
  778. HNPCC
  779. Herpes simplex
  780. Heterochromasia
  781. HHV-8
  782. Hidradenocarcinoma
  783. Hidradenoma
  784. Hidradenoma papilliferum
  785. Hidroacanthoma simplex
  786. Hidrocystoma
  787. High-frequency hearing loss
  788. Hirudo medicinalis
  789. Histiocytoma - cutis
  790. Histiocytosis-X
  791. HIV
  792. HIV infection
  793. HIV/AIDS
  794. HLA haplotype
  795. HLA-DQB1*03
  796. HLA-DR
  797. HLA-DR5
  798. HLA-DRB1*11
  799. HLA-DRB1*1104
  800. HMB-45
  801. HMSH2
  802. Hobnail haemangioma
  803. Hodgkin disease
  804. Hodgkin lymphoma - HL
  805. HOGG1
  806. HOI
  807. Homer Wright rosettes
  808. Hormonal contraceptives
  809. Horn cysts
  810. HOXC5
  811. HPV
  812. HPV-1
  813. HPV-2
  814. HPV-4
  815. HPV-6
  816. HPV-7
  817. HPV-11
  818. HPV-13
  819. HPV-16
  820. HPV-18
  821. HPV-31
  822. HPV-32
  823. HPV-54
  824. HPV-58
  825. HPV-61
  826. HPV-62
  827. HPV-63
  828. HPV-66
  829. HPV-73
  830. HRAS
  831. HRAS mutations
  832. HTLV-1
  833. HHV8
  834. Human immunodeficiency virus
  835. Human milk fat globule protein
  836. Human milk fat globulin 1 - HMFG
  837. HPV
  838. HTLV-1
  839. Hutchinson melanotic freckle
  840. Hutchinson sign
  841. Hutchinson’s melanotic freckle
  842. Hyaline collagen bundles
  843. Hyaline-cell rich chondroid syringoma
  844. Hyalinization
  845. Hyalinizing Spitz naevus
  846. Hyaluronidase resistance
  847. Hydroa vacciniforme-like cutaneous T-cell lymphoma
  848. Hydrolase alpha-galactosidase A
  849. Hyperchromasia
  850. Hypergammaglobulinemia
  851. Hyperkeratotic seborrhoeic keratosis
  852. Hypermelanotic naevi
  853. Hypersensitivity to insect bites
  854. Hypertension
  855. Hypertrophic scar
  856. Hypodontia
  857. Hypogonatrophic hypogonadism
  858. Hypopigmentation
  859. Hypopituitarism
  860. Hyporeflexia
  861. Hypotension
  862. Iatrogenic arteriovenous fistulas
  863. ICAM
  864. IgA
  865. IgE
  866. IGF-II
  867. IgG
  868. IKH-4
  869. IL-4
  870. IL-5
  871. IL-10
  872. Immature trichoepithelioma
  873. Immunoglobulin
  874. Immunosuppression
  875. In situ hybridization
  876. Indeterminate cell histiocytosis - ICH
  877. Indolent systemic mastocytosis
  878. Industrial carcinogens
  879. Infantile haemangioma
  880. Infantile melanoma
  881. Infantile myofibromatosis
  882. Infiltrating basal cell carcinoma
  883. Inflammatory angiomatous nodule
  884. Inflammatory molluscum contagiosum
  885. Inflammatory myofibroblastic pseudotumour
  886. Inflammatory pseudotumour - IPT
  887. Infundibular tumour
  888. Infundibulocystic basal cell carcinoma
  889. Infundibuloisthmicoma
  890. Ingrown toenail
  891. Inguinal hernia
  892. Inherited tumour syndromes
  893. Ink spot
  894. Ink spot lentigo
  895. INK4a
  896. Interferon
  897. Interleukin-3 receptor alpha chain (IL-3R-alpha).
  898. International Society for Cutaneous
  899. Lymphoma ISCL
  900. Intestinal ganglioneuromatosis
  901. Intradermal Spitz naevi
  902. Intraepidermal carcinoma
  903. Intraepidermal Merkel cell carcinoma
  904. Intra-epidermal proliferative disorders - dysplasias
  905. Intramuscular haemangioma
  906. Intravascular large B-cell lymphoma - IL
  907. Intravascular lymphoma
  908. Intravascular lymphomatosis
  909. Intravenous atypical vascular proliferation
  910. Invasive hair matrix tumour of the scalp
  911. Invasive pilomatrixoma
  912. Inverted type A naevus
  913. Involucrin
  914. Ionizing radiation
  915. Irregular acanthosis
  916. Irritated seborrhoeic keratosis
  917. Isochromosome 11p
  918. Isolated dyskeratosis follicularis
  919. Ixodes ricinus
  920. JH translocation
  921. Jun D
  922. Juvenile chronic myeloid leukaemia
  923. Juvenile haemangioma
  924. Juvenile polyposis syndrome
  925. Juvenile xanthogranuloma - JXG
  926. JXG see Juvenile xanthogranuloma
  927. K1 and K10 genes
  928. Kamino bodies
  929. Kaposi sarcoma
  930. Kaposiform haemangioendothelioma
  931. Kasabach-Merritt syndrome
  932. Keloid scar
  933. Keratin cysts
  934. Keratinocyte intraepidermal neoplasia - KIN I, II and III
  935. Keratinocytic tumours
  936. Keratinous microcysts
  937. Keratoacanthoma
  938. Keratoacanthoma centrifugum marginatum
  939. Keratocystic odontogenic tumours
  940. Keratoses
  941. Keratosis follicularis inversa
  942. Keratotic basal cell carcinoma
  943. Keratotic haemangioma
  944. Ketron-Goodman type
  945. Ki-67
  946. Kimura disease
  947. KIN see Keratinocyte intraepidermal neoplasia
  948. KIR receptors
  949. KIT
  950. Klippel-Trenaunay syndrome
  951. Klippel-Trenaunay-Weber syndrome
  952. Koebner phenomenon
  953. Koilocytes
  954. Koilocytosis
  955. Kostmann syndrome
  956. KP1
  957. K-ras
  958. Kyphoscoliosis
  959. Labial lentigo
  960. Labial melanotic macule
  961. Labial/oral melanosis
  962. Lactate dehydrogenase - LDH
  963. LAMB syndrome
  964. Laminin
  965. Langerhans cell disease
  966. Langerhans cell granules
  967. Langerhans cell granulomatosis
  968. Langerhans cell histiocytosis - LCH
  969. Langerhans cells
  970. Large cell acanthoma
  971. Richter syndrome
  972. Large plantar wart
  973. Latitudes
  974. Laugier-Hunziker syndrome
  975. LDH
  976. LEF-1
  977. Leiomyosarcoma
  978. Lentigines
  979. Lentiginosis-multiple endocrine neoplasia syndrome
  980. Lentiginous melanocytic naevus
  981. Lentiginous melanocytic proliferation
  982. Lentigo maligna melanoma - LMM
  983. Lentigo simplex
  984. Lentigo-melanosis
  985. Leonine facies
  986. LEOPARD syndrome
  987. Leser-Trélat syndrome
  988. Letterer-Siwe disease
  989. Leu M5
  990. Leu-7
  991. Leukaemia
  992. Leukocyte common antigen - LCA
  993. Leukocytosis
  994. Leukoderma
  995. Leukoderma acquisitum centrifugum
  996. Leukoplakia
  997. CD15
  998. Lewis Y antigen
  999. Lichen planus
  1000. Lichen planus-like keratosis - LPLK
  1001. Lichen sclerosus of the vulva
  1002. Lichenoid solar keratosis
  1003. Limbal dermoid
  1004. Linear skin defects
  1005. Lipoid dermatoarthritis
  1006. Lipoid rheumatism
  1007. Lipoma of the brain
  1008. Lipoma
  1009. Liver transplant
  1010. LMP-1
  1011. L-myc
  1012. Lobular capillary haemangioma
  1013. Lobular panniculitis
  1014. Local recurrence of melanoma
  1015. LOH at 9q22
  1016. Longitudinal melanonychia
  1017. Long-wave ultraviolet radiation - UVA
  1018. Loss of chromosome
  1019. Loss of heterozygosity - LOH
  1020. Loss of heterozygosity at 9p21 (p16)
  1021. Loss of heterozygosity at 9q22
  1022. Low-grade squamous cell carcinoma in situ
  1023. Low-molecular-weight keratins
  1024. Low-set ears
  1025. LPLK
  1026. Lumbosacral haemangioma
  1027. Lupus erythematosus
  1028. Lupus profundus pannicultis
  1029. Lymphadenoma - adamantanoid trichoblastoma
  1030. Lymphadenopathy
  1031. Lymphadenosis benigna cutis - LABC
  1032. Lymphangiectasias
  1033. Lymphangiography
  1034. Lymphangioma
  1035. Lymphangioma circumscriptum
  1036. Lymphangioma tuberosum multiplex
  1037. Lymphangioma-like Kaposi sarcoma
  1038. Lymphangiomatosis
  1039. Lymphangiosarcoma
  1040. Lymphatic tumours
  1041. Lymphoadenopathy
  1042. Lymphoblastic leukaemia/lymphoma
  1043. Lymphoblastic lymphoma
  1044. Lymphocytic infiltration
  1045. Lymphocytoma cutis
  1046. Lymphoedema
  1047. Lymphoid infiltrates of the skin mimicking lymphoma - cutaneous pseudolymphoma
  1048. Lymphomatoid contact dermatitis
  1049. Lymphomatoid granulomatosis - LYG
  1050. LyP
  1051. Lymphomesenteric cysts
  1052. Lymphoplasmacytoid cells
  1053. Lymphoscintigraphy
  1054. LyP see lymphomatoid papulosis
  1055. Lysozyme
  1056. MAC387
  1057. Macrocephaly
  1058. Maculopapular or plaque type mastocytosis
  1059. Maffucci syndrome
  1060. MAGE3
  1061. Malignant acrospiroma
  1062. Malignant angioendotheliomatosis
  1063. Malignant apocrine mixed tumour
  1064. Malignant blue naevus
  1065. Malignant chondroid syringoma
  1066. Malignant clear-cell acrospiroma
  1067. Malignant clear-cell hidradenoma
  1068. Malignant cutaneous melanoma
  1069. Malignant cylindroma
  1070. Malignant eccrine acrospiroma
  1071. Malignant eccrine poroma
  1072. Malignant fibrous histiocytoma - MFH
  1073. Malignant hidroacanthoma simplex
  1074. Malignant intraepidermal eccrine poroma
  1075. Malignant lymphoma
  1076. Malignant melanoma
  1077. Malignant melanoma arising in a garment naevus
  1078. Malignant melanoma arising in a giant hairy naevus
  1079. Malignant mixed tumour
  1080. Malignant nodular clear-cell hidradenoma
  1081. Malignant peripheral nerve sheath tumour
  1082. Malignant pilomatrixoma
  1083. Malignant spiradenoma
  1084. Mantle cell lymphoma
  1085. Mantleoma
  1086. Marginal zone B cell lymphoma
  1087. MART-1
  1088. Mast cell disease
  1089. Mast cell leukaemia
  1090. Mast cell proliferative disease
  1091. Mastocytoma
  1092. Mastocytosis
  1093. Mastocytosis with associated haematopoietic disorder
  1094. Matrical carcinoma
  1095. Matricoma
  1096. Matrix carcinoma
  1097. Matrix interacting protein 1 - MXI1
  1098. Mature B lymphocyte
  1099. Mature skin homing T cells
  1100. MC1R - Melanocortin 1 Receptor
  1101. MCC
  1102. MDM2
  1103. Medicinal leeches
  1104. Medullary carcinoma of the thyroid
  1105. Medulloblastoma
  1106. Melan-A
  1107. Melanoacanthoma
  1108. Melanoacanthosis
  1109. MC1R
  1110. MANIAC
  1111. Melanocytic macules of the lip
  1112. Melanocytic naevi
  1113. Melanocytic naevus with architectural disorder and cytologic atypia
  1114. Melanocytic naevus with phenotypic heterogeneity
  1115. Melanocytosis
  1116. Melanoma
  1117. Melanoma and neural system tumour syndrome
  1118. Melanoma arising in a bathing trunk naevus
  1119. Melanoma arising in giant congenital naevi
  1120. Melanoma arising in the dermal component of a large or “giant” congenital naevus
  1121. Melanoma arising from blue naevus
  1122. Melanoma familial, MLM
  1123. Melanoma in situ
  1124. Melanoma prevention
  1125. Melanoma-astrocytoma syndrome
  1126. Melanoma-inhibiting activity - MIA
  1127. Melanoma-pancreatic cancer syndrome
  1128. Melanoma simulating Spitz naevus
  1129. Mélanose circonscrite précancereuse
  1130. Melanosis
  1131. Melanosis circumscripta precancerosa
  1132. Melanosis of the nail bed and matrix
  1133. Melanotic macules
  1134. MEN2b
  1135. Meningeal melanocytoma (blue naevus) of the brain
  1136. Meningioma
  1137. Menzies method
  1138. Merkel cell carcinoma
  1139. Merkel cells
  1140. Merosin
  1141. Metastasizing Spitz naevus
  1142. Metastasizing squamous cell carcinoma
  1143. Metastatic adenosquamous carcinoma
  1144. Metastatic melanoma
  1145. Metastatic melanoma mimicking blue naevus
  1146. Metastatic neuroblastoma
  1147. Metastatic small cell neuroendocrine carcinoma
  1148. Metatypical carcinoma
  1149. Meyerson naevus
  1150. MIB-1 labeling index
  1151. Mibelli angiokeratoma
  1152. MIC2 gene product
  1153. Michelin tyre baby
  1154. Michelin tyre syndrome
  1155. Microcystic adnexal carcinoma
  1156. Micronodular basal cell carcinoma
  1157. Microphthalmia
  1158. MITF
  1159. Microphthalmia transcription factor - MITF-1
  1160. Microsatellite instability
  1161. Microvenular haemangioma
  1162. Microvesiculation
  1163. Milia
  1164. Minimal deviation melanoma
  1165. Mismatch repair genes
  1166. Mitogenicity
  1167. Mixed tumour of skin
  1168. MLH1
  1169. MMAC1
  1170. MNF116
  1171. MNNG
  1172. Moll gland carcinoma
  1173. Mongolian spot
  1174. Monomorphic NK-cell lymphoma
  1175. Morpheiform basal cell carcinoma
  1176. MSH-2
  1177. MTS
  1178. MTS1
  1179. Mucicarmine
  1180. Mucinous carcinoma
  1181. Mucoepidermoid carcinoma
  1182. Mucoepidermoid hidradenocarcinoma
  1183. Mucopolysaccharide
  1184. Mucopolysaccharidoses - including
  1185. Hurler and Hunter syndromes
  1186. Mucosa associated lymphoid tissue
  1187. MALT
  1188. Mucosal melanoma
  1189. Muir-Torre syndrome - MTS
  1190. Multicentric Castleman disease
  1191. Multicentric pigmented Bowen disease
  1192. Multicentric reticulohistiocytosis
  1193. Multifocal indolent pigmented penile papules
  1194. Multinodular goiter
  1195. Multiple cutaneous and uterine leiomyoma syndrome
  1196. Multiple enchondroma - Maffucci syndrome
  1197. Multiple endocrine neoplasia
  1198. Multiple endocrine neoplasia syndrome - MEN2b
  1199. Multiple facial angiofibroma
  1200. Multiple gastrointestinal polyps
  1201. Multiple Hama small blue round cell tumours
  1202. Multiple hamartoma and neoplasia syndrome
  1203. Multiple hamartoma syndrome
  1204. Multiple hamartomatous gastrointestinal polyps
  1205. Multiple lymphangiectasias
  1206. Multiple mucosal neuroma - MMN syndrome
  1207. Multiple pilomatricoma
  1208. Multiple tricholemmomas
  1209. MUM-1/IRF-4
  1210. Musculoskeletal abnormalities
  1211. Mustard gas
  1212. MXI1
  1213. Mycosis fungoides
  1214. Myelin basic protein
  1215. Myeloid leukaemia
  1216. Myoatrophy
  1217. MYO-D1
  1218. Myoepithelial carcinoma
  1219. Myofibroblastic dermatofibroma
  1220. Myofibromatosis
  1221. Myogenin
  1222. Myoglobin
  1223. Myositis
  1224. Myotonia
  1225. Myotonic dystrophy
  1226. Myrmecia
  1227. Myxoid dermatofibroma
  1228. Myxoid liposarcoma
  1229. Myxoid mammary fibroadenoma
  1230. Myxoid pseudocysts of the digits
  1231. Myxoma
  1232. Myxomatous perineuroma
  1233. Myxopapillary ependymoma
  1234. Naevi on volar skin
  1235. Naevi with dermal epithelioid cell components
  1236. Naevi with dermal nodules.
  1237. Naevoid basal cell carcinoma (Gorlin) syndrome see next line.
  1238. Naevoid basal cell carcinoma syndrome - NBCCS
  1239. Naevoid melanoma
  1240. Naevi
  1241. Naevus angiokeratoticus
  1242. Naevus flammeus
  1243. Naevus fuscoceruleus ophthalmomaxillaris
  1244. Naevus incipiens
  1245. Naevus keratoangiomatosus
  1246. Naevus lipomatosus
  1247. Naevus of Ito
  1248. Naevus of Ota
  1249. Naevus of spindled and/or epithelioid cells
  1250. Naevus of Sun
  1251. Naevus sebaceous
  1252. Naevus sebaceous of Jadassohn
  1253. Naevus spilus - congenital speckled lentiginous naevus
  1254. Naevus vascularis unius lateralis
  1255. Naevus with architectural disorder
  1256. Naevus with focal dermal epithelioid component
  1257. Nail dystrophy
  1258. NAME syndrome
  1259. Naturopathic medicines
  1260. Necrosis en masse
  1261. NER see Nucleotide excision repair
  1262. Nerve sheath myxoma/neurothekeoma
  1263. Nerve sheath tumours
  1264. Neurilemmomatosis
  1265. Neurocutaneous melanocytosis
  1266. Neuroendocrine carcinoma of the skin
  1267. Neurofibroma
  1268. Neurofibromatosis
  1269. Neurofibromatosis type 1 - NF1
  1270. Neurofibromatosis type 1 b - NF1b
  1271. Neurofibromatosis type 2 - NF2
  1272. Neurofibromatosis type 2 b - NF2b
  1273. Neurofilament
  1274. Neurofollicular hamartoma
  1275. Neuroma
  1276. Neuromuscular hamartoma
  1277. Neurotization
  1278. Neurotropism
  1279. Neutropaenia
  1280. Nevoxanthoendothelioma
  1281. NF1 see neurofibromatosis type - NF1
  1282. NF2 see Neurofibromatosis type - NF2
  1283. NGFR
  1284. Nickel
  1285. NK/T-cell lymphoma
  1286. NKI/C
  1287. Nodular amelanotic melanoma
  1288. Nodular angioblastic hyperplasia with eosinophilia and lymphofolliculosis
  1289. Nodular basal cell carcinoma
  1290. Nodular hidradenocarcinoma
  1291. Nodular hidradenoma
  1292. Nodular lymphocyte predominant
  1293. NLPHL
  1294. Nodular melanoma
  1295. Non-cutaneous melanoma
  1296. Non-diabetic cutaneous xanthomatosis
  1297. Non-encapsulated neuroma
  1298. Non-Hodgkin lymphoma
  1299. Non-inflammatory halo naevi
  1300. Non-Langerhans-cell - LC histiocytosis
  1301. Non-melanoma skin cancer - NMSC
  1302. Non-neuroendocrine small cell carcinoma
  1303. Non-regressing lipodystrophy centrifugalis abdominalis
  1304. Normocholesterolemic xanthomatosis
  1305. Npm-alk protein - p80
  1306. Nuclear pseudoinclusions
  1307. Nucleolar organizing regions - AgNORs
  1308. Nucleotide excision repair - NER
  1309. Ocular melanocytosis
  1310. Oculodermal melanocytosis
  1311. Odontogenic keratocysts
  1312. OKM1
  1313. OKT6
  1314. Oral contraceptives
  1315. Oral florid papillomatosis
  1316. Orange skin
  1317. Orbital melanoma
  1318. Organ transplantation
  1319. Ossification
  1320. Ossifying dermatofibroma with osteoclast-like giant cells
  1321. Osteoarthrosis
  1322. Osteolytic skull lesions
  1323. Osteoporosis
  1324. Otitis media
  1325. Ovarian fibroma
  1326. Ozone layer
  1327. p14ARF
  1328. p15
  1329. P16/INK4
  1330. p16INK4A
  1331. p19(ARF)
  1332. p21
  1333. p21 WAF1
  1334. p62
  1335. p75
  1336. P75 - low-affinity nerve growth factor receptor
  1337. Paget disease
  1338. Paget disease of breast
  1339. Paget disease - extramammary EPD
  1340. Pagetoid dyskeratosis
  1341. Pagetoid melanocytosis
  1342. Pagetoid melanoma
  1343. Pagetoid reticulosis
  1344. Pagetoid reticulosis of the Ketron Goodman type
  1345. Pagetoid Spitz naevus
  1346. Pagetoid upward migration
  1347. Pagetoid variant of Bowen disease
  1348. Pale cell acanthoma
  1349. Pale scar-like lesions
  1350. Palisaded, encapsulated neuroma - PEN
  1351. Palisading pattern
  1352. Palmar pits
  1353. Palmar-plantar-subungal-mucosal melanoma - P-S-M melanoma
  1354. Palmo-plantar keratoderma
  1355. Palpable migratory arciform erythema
  1356. Pan T-cell markers
  1357. Pancreatic cancer
  1358. Pan-cytokeratin
  1359. Pancytopenias
  1360. Pan-muscle actin - HHF-35
  1361. Panniculitis
  1362. Papillary apocrine gland cyst
  1363. Papillary thyroid carcinoma
  1364. Papillary tubular adenoma
  1365. Papillomatosis
  1366. Papillomatosis cutis carcinoides
  1367. Parakeratosis
  1368. Parakeratosis variegata
  1369. Parapsoriasis
  1370. Parapsoriasis - Large patch type, with or without poikiloderma
  1371. Parapsoriasis en grandes plaques poikilodermiques
  1372. Parapsoriasis en plaques - Brocq disease
  1373. Parapsoriasis lichenoides
  1374. Parasitosis
  1375. PATCHED1
  1376. Pautrier microabscesses
  1377. PCFCL
  1378. PCNA
  1379. Peanut agglutinin - PNA
  1380. Peliosis hepatis
  1381. Pemphigus
  1382. PEN
  1383. Penile intraepithelial neoplasia
  1384. Penile lentigo
  1385. Penile melanotic macule
  1386. Peptic ulcer disease
  1387. Perforin
  1388. Pericarditis
  1389. Perifollicular fibroma
  1390. Perifollicular fibrous papule
  1391. Perinaevic eczema
  1392. Perineural invasion
  1393. Perineural lymphocytes
  1394. Perineurial cells
  1395. Période érythémateuse
  1396. Période fongoïdique
  1397. Période lichénoïde
  1398. Peripheral myelin proteins
  1399. Peripheral neuroblastoma
  1400. Peripheral neuroepithelioma
  1401. Peripheral T-cell lymphoma
  1402. Peripheral vascular atherosclerosis
  1403. Periungual fibroma of tuberous sclerosis - Koenen tumours
  1404. Perls stain
  1405. Persistent (recurrent) melanocytic naevus
  1406. Persistent and metastatic melanoma
  1407. Persistent melanocytic naevi
  1408. Persistent melanoma
  1409. Persistent nodular arthropod-bite reactions
  1410. Peutz-Jeghers syndrome
  1411. PGM1
  1412. PGP 9.5
  1413. PHACES syndrome
  1414. Pheochromocytoma
  1415. Phlebitis
  1416. Phosphatidylinositol-3-kinase (PI3K)/Akt pathway
  1417. Phosphorylated mitogen-activated protein kinase
  1418. Photochemotherapy
  1419. PI3K/Akt pathway see phosphatidylinositol-kinase (PI3K)/Akt pathway
  1420. Pian fungoides
  1421. Pigment incontinence
  1422. Pigmented basal cell carcinoma
  1423. Pigmented seborrhoeic keratosis
  1424. Pigmented spindle cell naevus
  1425. Pigmented spindle cell naevus (Reed)
  1426. Pigmented spindle cell naevus with architectural and/or cytologic atypia
  1427. Pigmented xerodermoid
  1428. Pilar leiomyoma
  1429. Pilar sheath acanthoma
  1430. Piloleiomyoma
  1431. Pilomatrical carcinoma
  1432. Pilomatricoma
  1433. Pilomatrix carcinoma
  1434. Pilomatrixoma
  1435. Pilosebaceous pathway of differentiation
  1436. Pilotropic mycosis fungoides - MF
  1437. Pinkus tumour
  1438. Pits
  1439. Pityriasis rosea
  1440. Plantar wart
  1441. Plaque-like dermal fibromatosis
  1442. Plasma cell granuloma
  1443. Plasmablastic lymphoma
  1444. Pleomorphic fibroma
  1445. Pleuritis
  1446. Plexiform pigmented spindle cell naevus
  1447. Plexiform spindle cell naevus
  1448. PNET/ES
  1449. POEMS syndrome
  1450. Poikiloderma
  1451. Poikiloderma vasculare atrophicans
  1452. POLh
  1453. white hair
  1454. Polycyclic aromatic hydrocarbons
  1455. Polymyalgia rheumatica
  1456. Porocarcinoma
  1457. Poroepithelioma
  1458. Poroid hidradenoma
  1459. Poroma
  1460. pRb
  1461. Precursor B-lymphoblastic leukaemia
  1462. Precursor B-lymphoblastic lymphoma
  1463. Precursor lymphoblastic lymphoma
  1464. Precursor lymphoblastic leukaemia
  1465. Precursor T-lymphoblastic leukaemia
  1466. Precursor T-lymphoblastic lymphoma
  1467. Pregnancy
  1468. Prelymphomatous disorders - PLD
  1469. Abortive disorders
  1470. Prereticulotic poikiloderma
  1471. Primary cutaneous adenoid cystic carcinoma
  1472. Primary cutaneous aggressive epidermotropic CD8+ cytotoxic Tcell lymphoma
  1473. Primary cutaneous anaplastic large-cell lymphoma
  1474. Primary cutaneous anaplastic lymphoma - C-ALCL
  1475. Primary cutaneous B cell lymphoma - CBCL
  1476. Primary cutaneous diffuse large Bcell lymphoma - DLBCLs
  1477. Primary cutaneous follicle centre lymphoma - PCFCL
  1478. Primary cutaneous immunocytoma/ marginal zone B-cell lymphoma
  1479. Primary cutaneous large B-cell lymphoma
  1480. Primary cutaneous large cell T cell lymphoma CD30+
  1481. Primary cutaneous marginal zone B-cell lymphoma - MZL
  1482. Primary cutaneous mucinous carcinoma
  1483. Primary cutaneous T-cell lymphoma
  1484. Primary cutaneous peripheral Tcell lymphoma
  1485. Primary cutaneous plasmacytoma
  1486. Primary cutaneous small-medium CD4+ T-cell lymphoma
  1487. Primary malignant peripheral primitive neuroectodermal tumour (PNET)
  1488. Extraskeletal Ewing sarcoma - ES
  1489. Primary mucoepidermoid carcinoma of the skin
  1490. Primary small-cell carcinoma of the skin
  1491. Primary systemic anaplastic large cell lymphoma
  1492. PRKAR1A
  1493. Progesterone receptor
  1494. Progressive and recurring dermatofibroma
  1495. Progressive atrophying chronic granulomatous dermohypodermitis
  1496. Progressive capillary haemangioma
  1497. Progressive lymphangioma
  1498. Proliferating epidermoid cyst
  1499. Proliferating follicular cystic neoplasm
  1500. Proliferating isthmic cystic carcinoma
  1501. Proliferating pilar cyst
  1502. Proliferating tricholemmal cyst
  1503. Proliferating tricholemmal cystic squamous cell carcinoma
  1504. Proliferating tricholemmal tumour
  1505. Proliferative nodules in a congenital naevus
  1506. Proliferative nodules in congenital melanocytic naevi
  1507. Prolymphocytic leukaemia
  1508. Prostate carcinoma
  1509. Proteinuria
  1510. Proteoglycans
  1511. Proteus syndrome
  1512. Proteus-like (non-CS, non-BRR) syndromes
  1513. Pruritus
  1514. Psammoma bodies
  1515. Psammomatous melanotic schwannoma
  1516. Pseudoangiomatous squamous cell carcinoma - SCC
  1517. Pseudoangiosarcomatous squamous cell carcinoma - SCC
  1518. Pseudo-Darier sign
  1519. Pseudoglandular squamous cell carcinoma
  1520. Pseudoinclusions
  1521. Pseudolymphoma - PSL
  1522. TPSL
  1523. Pseudolymphoma of Spiegler and Fendt
  1524. Pseudomelanoma
  1525. Pseudo-T-cell lymphoma
  1526. Pseudovascular squamous cell carcinoma - SCC
  1527. P-S-M melanoma
  1528. Psoralen
  1529. Psoriasis
  1530. PTCH gene 9q22
  1531. PTEN hamartoma tumour syndrome - PHTS
  1532. PTEN gene
  1533. Purpura
  1534. Pushing pattern of growth
  1535. PUVA - psoralens + UVA
  1536. PUVA keratosis
  1537. PUVA-lentigines
  1538. Pyogenic granuloma
  1539. Pyrimidine dimers
  1540. RAB5
  1541. Racemiform trichoblastoma
  1542. Radiation therapy
  1543. Radical mastectomy - Stewart
  1544. Treves
  1545. RAP1
  1546. RAS
  1547. RasGTPase activating protein
  1548. Rb
  1549. Reactive angioendotheliomatosis
  1550. Reactive lymphoid hyperplasias - RLH
  1551. Reactive oxygen species - ROS
  1552. REAL classification
  1553. Receptor tyrosine kinase
  1554. RECQL
  1555. RECQL
  1556. Recurrent naevus
  1557. Reed naevus
  1558. Reed tumour
  1559. Reed-Sternberg cells - RS cells
  1560. Regressing atypical histiocytosis
  1561. Regression
  1562. Renal carcinoma
  1563. RET proto-oncogene
  1564. Reticulated black solar lentigo
  1565. Reticulated melanotic macule
  1566. Reticulated seborrhoeic keratosis
  1567. Reticulohistiocytic granuloma
  1568. Reticulohistiocytoma cutis
  1569. Reticulohistiocytoma of the dorsum - Crosti disease
  1570. Reticulohistiocytosis
  1571. Reticulohistiocytosis of the skin and synovia
  1572. Reticulomatosis with giant cell histiocytes
  1573. Rhabdoid squamous cell carcinoma - SCC
  1574. Rhabdomyomatous mesenchymal hamartoma - RMH
  1575. Rhabdomyomatous mesenchymal hamartoma - striated muscle hamartoma
  1576. Rhabdomyosarcoma
  1577. Rheumatoid arthritis
  1578. Rhinophyma
  1579. RhoB
  1580. Richter syndrome
  1581. Rosai-Dorfman disease
  1582. Rothmund-Thomson syndrome
  1583. Rubinstein-Taybi syndrome
  1584. Rudimentary Verocay bodies
  1585. S-100-beta
  1586. Sarcoidosis
  1587. Sarcoma
  1588. Scattered Factor XIIIa
  1589. Squamous cell carcinoma
  1590. Schöpf-Schultz-Passarge syndrome
  1591. Schwann cells
  1592. Schwannoid basal cell carcinoma - BCC
  1593. Schwannoma
  1594. Sclerocornea
  1595. Scleroderma-like Skin Changes
  1596. Sclerosing basal cell carcinoma - BCC
  1597. Sclerosing cellular blue naevi
  1598. Sclerosing epithelial hamartoma
  1599. Sclerosing haemangioma
  1600. Sclerosing sweat duct carcinoma
  1601. Sclerotic fibroma
  1602. Sclerotic or sclerosing fibroma
  1603. Scrotal condylomata
  1604. Sebaceoma
  1605. Sebaceous adenoma
  1606. Sebaceous carcinoma
  1607. Sebaceous epithelioma
  1608. Sebaceous trichofolliculoma
  1609. Sebocytes
  1610. Sebomatricoma
  1611. Seborrhoeic keratosis
  1612. Seborrhoeic wart
  1613. Secondary cutaneous follicular lymphoma - FL
  1614. Secundary skin involvement by diffuse large B-cell lymphoma
  1615. Segmental regression
  1616. Seizures
  1617. Senile haemangioma
  1618. Senile wart
  1619. Sentinel node - SN biopsy
  1620. Sertoli cell tumours of the testes
  1621. Sessile masses
  1622. Sézary cells
  1623. Sézary syndrome
  1624. Shadow cells
  1625. SHH signalling pathway see Sonic
  1626. Hedgehog
  1627. Shortened telomere length
  1628. Shoulder phenomenon
  1629. Signet ring cell apocrine carcinoma - AC
  1630. Signet-ring squamous ceel carcinoma - SCC
  1631. Simple lentigo
  1632. Simple lentigo and lentiginous melanocytic naevus
  1633. Sinus histiocytosis with massive lymphadenopathy - Rosai Dorfman disease
  1634. Sinusoidal haemangioma
  1635. Sinusoidal pattern
  1636. Site specific and Meyerson naevi
  1637. Sjögren syndrome
  1638. Skin homing T-cells
  1639. Skin homing T-helper cells
  1640. Skin surface microscopy
  1641. Skin type I
  1642. Skin type II
  1643. Skin types I and II
  1644. Small cell melanoma
  1645. Small cell naevoid melanoma
  1646. milia
  1647. Small lymphocytic lymphoma
  1648. Small plaque parapsoriasis
  1649. Smallpox
  1650. Smooth and skeletal muscle tumours
  1651. Smooth muscle hamartoma
  1652. SMOOTHENED
  1653. Socio-economic status
  1654. Solar keratoses
  1655. Solar lentigo
  1656. lentigo senilis
  1657. Solid-cystic hidradenoma
  1658. Solitary angiokeratoma
  1659. Solitary circumscribed neuroma
  1660. Solitary cutaneous myofibroma.
  1661. Solitary cutaneous reticulohistiocytosis - SCR
  1662. Solitary mastocytoma
  1663. Solitary sclerotic fibroma
  1664. Somatostatin
  1665. Sonic Hedgehog - SHH
  1666. Spinal dysraphism
  1667. Spinal malformation
  1668. Spindle and epithelioid cell naevus
  1669. Spindle cell haemangioendothelioma
  1670. Spindle cell haemangioma
  1671. Spindle cell melanoma
  1672. Spindle-cell squamous cell carcinoma
  1673. Spiradenocarcinoma
  1674. Spiradenocylindroma
  1675. Spiradenoma
  1676. Spitz naevi
  1677. Spitzoid melanoma
  1678. Spitzoid variant of naevoid melanoma
  1679. Splaying of melanocytes
  1680. Splenomegaly
  1681. Spongiotic change in melanocytic naevi
  1682. Spongiotic dermatitis involving melanocytic naevi
  1683. Spontaneous neuroma
  1684. Sprengel anomaly
  1685. Sprengel deformity
  1686. Squamoid sebaceous carcinoma
  1687. Squamous cell carcinoma
  1688. Squamous cell carcinoma de novo
  1689. Squamous cell carcinoma in situ - SCCIS
  1690. Squamous eddies
  1691. Sternal cleft defects
  1692. Stewart-Treves syndrome
  1693. Storiform collagenoma
  1694. Striated muscle hamartoma
  1695. Stromelysin
  1696. Stucco keratosis
  1697. Subcutaneous panniculitis-like Tcell lymphoma - SPTCL
  1698. Subcutaneous T-cell lymphoma
  1699. Subepidermal acanthoma
  1700. Subepidermal fibrin deposits
  1701. Subepidermal nodular fibrosis
  1702. Sub-papillary vascular plexus
  1703. Subungal and periungual fibroma
  1704. Subungual haematoma
  1705. Subungual keratoacanthoma
  1706. Subungual melanoma
  1707. Sulphur
  1708. Sun exposure
  1709. Sunburns
  1710. Sunscreens
  1711. Superficial basal cell carcinoma
  1712. mosaic warts
  1713. Superficial spreading malignant melanoma - SSMM
  1714. Superficial warts - mosaic
  1715. Supernumerary digit
  1716. Surface immunoglobulins - sIg
  1717. Sutton naevus
  1718. Sweat gland carcinoma
  1719. Sweat gland tumour
  1720. Synaptophysin
  1721. Syringoacanthoma
  1722. Syringoadenoma
  1723. Syringocystadenoma papilliferum
  1724. Syringocystadenoma
  1725. Syringofibroadenoma
  1726. Syringofibroadenomatosis
  1727. Syringoma
  1728. Syringomatous carcinoma
  1729. Syringotropic mucosis fungoides - MF
  1730. ALCL
  1731. Systemic cystic angiomatosis
  1732. T(11;14)(q13;q32) translocation
  1733. T(11;18) involving the API2/MLT genes
  1734. Tachycardia
  1735. Tardive congenital naevus
  1736. Targetoid haemosiderotic haemangioma
  1737. Tax
  1738. T-cell / histiocyte-rich large Bcell lymphoma
  1739. T-cell associated antigens
  1740. T-cell clonality in angiolymphoid hyperplasia with eosinophilia - ALHE
  1741. TIA-1
  1742. T-cell lymphoblastic leukaemia
  1743. T-cell lymphoblastic lymphoma
  1744. T-cell lymphoma
  1745. T-cell receptor
  1746. T-cell receptor gamma gene rearrangement
  1747. T-cell/histiocyte-rich large B-cell lymphoma
  1748. TCL1
  1749. TCR gene
  1750. TCR-beta
  1751. TCR-d
  1752. TCRd1
  1753. TdT
  1754. Telangiectasia
  1755. Telangiectasia macularis eruptiva perstans
  1756. Telangiectatic mastocytosis
  1757. Telomeric exhaustion
  1758. Tenascin
  1759. Tethered cord syndrome
  1760. TGF-beta
  1761. TGF-beta receptor I and II
  1762. TH2
  1763. The cutaneous lymphocyte antigen - CLA, HECA-452
  1764. Thomsen-Friedenreich antigen
  1765. Thrombocytopaenia
  1766. Thrombophlebitis
  1767. Thrombosis
  1768. Thymidine dimer formation
  1769. Thyroglossal duct sinus
  1770. Thyroid adenoma
  1771. Thyroid tumours
  1772. Thyroid-transcription factor
  1773. TIA-1
  1774. TIG-3
  1775. Tingible body macrophages
  1776. TMEP see Telangiectasia macularis eruptiva perstans
  1777. Tobacco use
  1778. Touton giant cells
  1779. Trabecular carcinoma
  1780. Transforming growth factor-b
  1781. Translocation
  1782. Translocation between the X and Y chromosomes
  1783. Translocation t(2;5) - p23;q35
  1784. Translocation t(11;22)(q24;q12)
  1785. Transplant patient
  1786. Traumatic neuroma
  1787. Trichilemmoma
  1788. Trichoblastic (basal cell) carcinoma
  1789. Trichoblastic carcinoma
  1790. Trichoblastic fibroma
  1791. Trichoblastoma
  1792. Trichochlamydocarcinoma
  1793. Trichodiscoma
  1794. Trichoepithelioma
  1795. Trichofolliculoma
  1796. Trichogerminoma
  1797. Trichohyaline granules
  1798. Tricholemmoma
  1799. Trichothiodystrophy (TTD
  1800. Trisomy 8
  1801. Trisomy 21
  1802. Triton tumour
  1803. TSC1 - tuberous scleosis gene 1
  1804. TSC2 - tuberous scleosis gene 2
  1805. TTF-1 - thyroid-transcription factor
  1806. Tuberin
  1807. Tuberous sclerosis
  1808. Tubular adenoma
  1809. Tubular apocrine adenoma
  1810. Tubular carcinoma
  1811. Tubular papillary adenoma
  1812. Tubulopapillary hidradenoma
  1813. Tufted angioma
  1814. Tufted haemangioma
  1815. Tumour of the follicular infundibulum
  1816. Tumoural melanosis
  1817. Turban tumour
  1818. Turner syndrome
  1819. Tyndall effect
  1820. Type IV collagen
  1821. Types II and IV collagen
  1822. Tyrosinase activity
  1823. Tyrosine kinase
  1824. Ulex europaeus I lectin
  1825. Ultraviolet A - UVA
  1826. Ultraviolet B radiation
  1827. Ultraviolet radiation
  1828. Unclassified plantar melanoma
  1829. Ungual melanosis
  1830. Ungual melanotic macule
  1831. Unilateral verrucous haemangioma
  1832. Unscheduled DNA synthesis
  1833. Upper extremity and syndactyly
  1834. Urticaria pigmentosa
  1835. UVR
  1836. Uveal melanoma - UM
  1837. Ultraviolet radiation
  1838. Vaccination
  1839. Vaccination scars
  1840. Vaccinia vaccine
  1841. Valvular cardiac disease
  1842. Varicelliform scars
  1843. Varicocoele
  1844. VEGFR-3
  1845. Vascular malformations
  1846. Vascular tumours
  1847. Vasculitis
  1848. Vd2
  1849. Vascular endothelial growth factor receptor
  1850. Venous malformation
  1851. Venous ulcer
  1852. Verruca peruana
  1853. Verruca plana
  1854. Verruca plana juvenilis
  1855. Verruca plantaris
  1856. Verruca vulgaris
  1857. Verrucae palmares - deep palmar or hand warts
  1858. Verrucae planae - plane warts, flat warts
  1859. Verrucae plantares - deep foot warts, myrmecia
  1860. common warts
  1861. Verrucas
  1862. Verrucous carcinoma
  1863. Verrucous haemangioma
  1864. Verrucous melanoma
  1865. Verrucous phenotype
  1866. Verrucous squamous cell carcinoma
  1867. Verruga peruana
  1868. Vinyl chloride
  1869. Vitiligo
  1870. Volar melanosis
  1871. Volar melanotic macule
  1872. Von Recklinghausen disease
  1873. Vulvar intraepithelial neoplasia - VIN III
  1874. Vulvar melanoma
  1875. Vulvar melanotic macule
  1876. Vulvar naevi
  1877. VWF - von Willebrand factor VIIIrAg
  1878. Wart
  1879. Warty dyskeratoma
  1880. Weibel-Palade bodies
  1881. Werner syndrome b
  1882. Wiskott-Aldrich syndrome
  1883. Witten and Zak type
  1884. Wolffian ducts
  1885. Woringer-Kolopp disease - WKD
  1886. Xanthoerythrodermia perstans
  1887. Xanthogranuloma
  1888. Xanthoma multiplex
  1889. Xanthomatous
  1890. Xeroderma pigmentosum - XP
  1891. Xeroderma pigmentosum variant
  1892. X-linked lymphoproliferative syndrome
  1893. XP see Xeroderma pigmentosum
  1894. XP Complementation groups
  1895. XP Microdeletion syndrome
  1896. XPA
  1897. XPB
  1898. XPC
  1899. XPD
  1900. XPE
  1901. XPF
  1902. XPG
  1903. ZAP-70
Retrieved from "https://en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Medicine/Dermatology_task_force/Missing_articles/LeBoit&oldid=381985355"